{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-26-000021","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.806524+00:00","generated_at":"2026-05-15T21:42:45.933813+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Keros Therapeutics updates corporate presentation; no material new disclosures in filing","bullets":["Company furnished a corporate presentation dated March 2026 for investor meetings.","Presentation is available on Keros's website; no forward-looking statements or specific data excerpted.","No financial results, pipeline milestones, or guidance changes were disclosed in the filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-26-000021","json":"https://secwatch.observer/filing/0001664710-26-000021.json","markdown":"https://secwatch.observer/filing/0001664710-26-000021.md","text":"https://secwatch.observer/filing/0001664710-26-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000021/0001664710-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000021/kros-20260304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:42:45.933813+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}